TWO SIGMA ADVISERS, LP - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 336 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2018. The put-call ratio across all filers is 2.21 and the average weighting 0.2%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$17,142,000
+68.4%
737,618
+15.3%
0.05%
+64.3%
Q1 2018$10,181,000
-65.7%
639,518
-55.2%
0.03%
-65.0%
Q4 2017$29,683,000
+10615.9%
1,428,418
+7294.2%
0.08%
+7900.0%
Q3 2017$277,000
-96.3%
19,318
-95.6%
0.00%
-96.0%
Q2 2017$7,583,000
+489.2%
438,338
+275.7%
0.02%
+525.0%
Q1 2017$1,287,000
-95.5%
116,664
-94.1%
0.00%
-96.4%
Q4 2016$28,864,000
+530.8%
1,987,851
+774.8%
0.11%
+378.3%
Q2 2016$4,576,000
+341.3%
227,231
+3809.0%
0.02%
+228.6%
Q3 2015$1,037,000
-77.4%
5,813
-71.9%
0.01%
-80.0%
Q2 2015$4,590,000
+808.9%
20,672
+485.4%
0.04%
+775.0%
Q4 2014$505,000
-81.9%
3,531
-83.4%
0.00%
-81.8%
Q3 2014$2,786,000
-91.9%
21,231
-92.3%
0.02%
-91.9%
Q2 2014$34,586,000
+13.7%
274,231
+18.9%
0.27%
-2.5%
Q1 2014$30,418,000
+233.1%
230,731
+163.6%
0.28%
+154.1%
Q3 2013$9,131,00087,5310.11%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q1 2018
NameSharesValueWeighting ↓
ACCIPITER CAPITAL MANAGEMENT, LLC 2,373,210$47,796,00039.06%
Claren Road Asset Management, LLC 77,527$1,561,00018.46%
Okumus Fund Management Ltd. 4,242,012$85,434,00014.79%
Chou Associates Management 1,446,843$29,139,00011.12%
FARLEY CAPITAL L.P. 307,458$6,192,0009.65%
HAP Trading, LLC 3,129,700$112,397,0006.58%
Pershing Square Capital Management 21,591,122$434,845,0005.79%
NORTH TIDE CAPITAL, LLC 2,500,000$50,350,0005.61%
Convector Capital Management, LP 192,000$3,867,0005.34%
Nebula Capital Management, LP 31,770$640,0005.07%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders